For patients with obesity, clinicians should move beyond a "try and fail" approach to lifestyle interventions and prioritize ...

The conversation around Semaglutide, known widely by brand names like Ozempic and Wegovy, has undeniably captured global ...

A federal judge in Texas has upheld the FDA’s decision to remove GLP-1 drugs, including Novo Nordisk’s Ozempic and Wegovy, from its drug shortage list, rejecting a bid by compounding pharmacies to ...

SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...

Share on Pinterest Ozempic, the active ingredient of which is semaglutide ... which included having an urgent medical visit or hospitalization from heart failure and death from cardiovascular ...

Without effective interventions, the global burden of obesity and its complications will continue to rise,” said Stephen Gough, senior vice president and head of Chief Medical Office ... after ...

There are a few cases when you shouldn’t take semaglutide, like if you’re pregnant or breastfeeding. A healthcare professional can give you medical advice that takes into account your weight ...

Using semaglutide injections ... senior vice president of clinical development, medical and regulatory affairs at Novo Nordisk, maker of Ozempic and Wegovy, in a press release provided to Fox ...

Michael Siluk/UCG/Universal Images Group via Getty Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, is poised to add to its growing list of medical uses. In a large-scale ...

The main aim was to compare the medical reports of semaglutide-related vision impairment to those associated with other antidiabetic and weight loss medicines. The study found semaglutide’s ...